SECURITIES AND EXCHANGE COMMISSION

                           Washington, D.C. 20549



                                  FORM 8-K


                               CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of
                    the Securities Exchange Act of 1934



                             November 18, 1999
              Date of Report (Date of earliest event reported)



                           WARNER-LAMBERT COMPANY
           (Exact name of registrant as specified in its charter)

                                  Delaware
               (State or other jurisdiction of incorporation)


            1-3608                              22-1598912
     (Commission File Number)       (IRS Employer Identification No.)


      201 Tabor Road, Morris Plains, New Jersey       07950-2693
      (Address of principal executive offices)        (Zip Code)


                               (973) 540-2895
            (Registrant's telephone number, including area code)


Item 5.  Other Events.

             A copy of the visual portion of the presentation provided with
respect to the joint American Home Products Corporation ("AHP") and
Warner-Lambert Company ("Warner-Lambert") meeting with analysts (the "Joint
Analyst Presentation") is filed as Exhibit 99.1 hereto, and is incorporated
herein by reference.

             Statements made in the Joint Analyst Presentation that state
the intentions, beliefs, expectations or predictions of AHP,
Warner-Lambert, or their respective managements for the future are
forward-looking statements. It is important to note that both AHP's and
Warner-Lambert's actual results could differ materially from those
projected in such forward-looking statements. Information concerning
factors that could cause actual results to differ materially from those in
forward-looking statements is contained from time to time in the filings of
each of AHP and Warner-Lambert with the U.S. Securities and Exchange
Commission (the "SEC"). Copies of these filings may be obtained by
contacting AHP or Warner-Lambert, as applicable, or the SEC.

            INVESTORS ARE URGED TO READ THE JOINT PROXY
STATEMENT/PROSPECTUS INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO (THE
"JOINT PROXY STATEMENT/PROSPECTUS") WHICH WILL BE PREPARED BY
WARNER-LAMBERT, WOLVERINE SUB CORP., A DELAWARE CORPORATION AND A WHOLLY
OWNED SUBSIDIARY OF AHP, AND AHP IN CONNECTION WITH THE TRANSACTIONS
CONTEMPLATED BY THE AGREEMENT AND PLAN OF MERGER, DATED AS OF NOVEMBER 3,
1999, AMONG WARNER-LAMBERT, WOLVERINE SUB CORP. AND AHP. INVESTORS ARE
URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS BECAUSE IT WILL CONTAIN
IMPORTANT INFORMATION TO INVESTORS. WHEN COMPLETED, THE JOINT PROXY
STATEMENT/PROSPECTUS WILL BE MAILED TO THE SHAREHOLDERS OF EACH COMPANY.
COPIES OF THE JOINT PROXY STATEMENT/PROSPECTUS MAY BE OBTAINED FOR FREE BY
CONTACTING WARNER-LAMBERT OR AHP AND AT THE SEC'S WEB SITE AT WWW.SEC.GOV.

Item 7.  Financial Statements and Exhibits

      (c)   Exhibits

            (99.1)  Joint Analyst Presentation




                                 SIGNATURE


            Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.



                              WARNER-LAMBERT COMPANY


                              By: /s/  Rae G. Paltiel
                                 --------------------------------
                              Name:  Rae G. Paltiel
                              Title: Secretary



Dated:  November 22, 1999







                               EXHIBIT INDEX


      (99.1)  Joint Analyst Presentation
[{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 3715}]
{"company-data": {"conformed-name": "WARNER LAMBERT CO", "cik": "0000104669", "assigned-sic": "2834", "irs-number": "221598912", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-03608", "film-number": "99761743"}, "business-address": {"street1": "201 TABOR RD", "city": "MORRIS PLAINS", "state": "NJ", "zip": "07950", "phone": "9735402895"}, "mail-address": {"street1": "201 TABOR ROAD", "city": "MORRIS PLAINS", "state": "NJ", "zip": "07950"}, "former-company": {"former-conformed-name": "WARNER LAMBERT PHARMACEUTICAL CO", "date-changed": "19701230"}}
SECURITIES AND EXCHANGE COMMISSION

                           Washington, D.C. 20549

                                  FORM 8-K

                               CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of
                    the Securities Exchange Act of 1934

                             November 18, 1999
              Date of Report (Date of earliest event reported)

                           WARNER-LAMBERT COMPANY
           (Exact name of registrant as specified in its charter)

                                  Delaware
               (State or other jurisdiction of incorporation)

            1-3608                              22-1598912
     (Commission File Number)       (IRS Employer Identification No.)

      201 Tabor Road, Morris Plains, New Jersey       07950-2693
      (Address of principal executive offices)        (Zip Code)

                               (973) 540-2895
            (Registrant's telephone number, including area code)

Item 5.  Other Events.

             A copy of the visual portion of the presentation provided with
respect to the joint American Home Products Corporation ("AHP") and
Warner-Lambert Company ("Warner-Lambert") meeting with analysts (the "Joint
Analyst Presentation") is filed as Exhibit 99.1 hereto, and is incorporated
herein by reference.

             Statements made in the Joint Analyst Presentation that state
the intentions, beliefs, expectations or predictions of AHP,
Warner-Lambert, or their respective managements for the future are
forward-looking statements. It is important to note that both AHP's and
Warner-Lambert's actual results could differ materially from those
projected in such forward-looking statements. Information concerning
factors that could cause actual results to differ materially from those in
forward-looking statements is contained from time to time in the filings of
each of AHP and Warner-Lambert with the U.S. Securities and Exchange
Commission (the "SEC"). Copies of these filings may be obtained by
contacting AHP or Warner-Lambert, as applicable, or the SEC.

            INVESTORS ARE URGED TO READ THE JOINT PROXY
STATEMENT/PROSPECTUS INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO (THE
"JOINT PROXY STATEMENT/PROSPECTUS") WHICH WILL BE PREPARED BY
WARNER-LAMBERT, WOLVERINE SUB CORP., A DELAWARE CORPORATION AND A WHOLLY
OWNED SUBSIDIARY OF AHP, AND AHP IN CONNECTION WITH THE TRANSACTIONS
CONTEMPLATED BY THE AGREEMENT AND PLAN OF MERGER, DATED AS OF NOVEMBER 3,
1999, AMONG WARNER-LAMBERT, WOLVERINE SUB CORP. AND AHP. INVESTORS ARE
URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS BECAUSE IT WILL CONTAIN
IMPORTANT INFORMATION TO INVESTORS. WHEN COMPLETED, THE JOINT PROXY
STATEMENT/PROSPECTUS WILL BE MAILED TO THE SHAREHOLDERS OF EACH COMPANY.
COPIES OF THE JOINT PROXY STATEMENT/PROSPECTUS MAY BE OBTAINED FOR FREE BY
CONTACTING WARNER-LAMBERT OR AHP AND AT THE SEC'S WEB SITE AT WWW.SEC.GOV.

Item 7.  Financial Statements and Exhibits

      (c)   Exhibits

            (99.1)  Joint Analyst Presentation

                                 SIGNATURE

            Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                              WARNER-LAMBERT COMPANY

                              By: /s/  Rae G. Paltiel
                                 --------------------------------
                              Name:  Rae G. Paltiel
                              Title: Secretary

Dated:  November 22, 1999

                               EXHIBIT INDEX

      (99.1)  Joint Analyst Presentation